The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies

Medicine (United States)

Volumn 92, Issue 4, 2013, Pages 223-243

  Rider, Lisa G ^a   Shah, Mona ^a,b   Mamyrova, Gulnara ^a,c   Huber, Adam M ^e   Rice, Madeline Murguia ^b   Targoff, Ira N ^d   Miller, Frederick W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c Department of Medicine ^*  (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 [4 (2 DIETHYLAMINOETHYLAMINO) 3 NITROPHENYL] 1,4 DIPHENYL 1,2,4 TRIAZOLIUM 3 THIOLATE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CREATINE KINASE; SIGNAL RECOGNITION PARTICLE; SYNTHETASE;

ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE COURSE; DYSPHONIA; ETHNICITY; FEMALE; HISPANIC; HUMAN; INTERSTITIAL LUNG DISEASE; JUVENILE DERMATOMYOSITIS; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; MUSCLE WEAKNESS; MYOSITIS; NEGRO; PAPULE; PHENOTYPE; PHOTOSENSITIVITY; POLYMYOSITIS; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOM FOREST; RASH; RAYNAUD PHENOMENON; UNIVARIATE ANALYSIS; WHEELCHAIR;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; MYOSITIS; PHENOTYPE;

EID: 84880288386     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31829d08f9     Document Type: Article

References (10)

1. Betteridge ZE, Gunawardena H, McHugh NJ. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther. 2011;13:209.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis. Parts 1 and 2. N Engl J Med. 1975;292:344-347, 3403-3407.
3. Ceribelli A, Fredi M, Taraborelli M, et al. Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/ dermatomyositis. Arthritis Res Ther. 2012;14:R97.
4. Chinoy H, Adimulam S, Marriage F, et al. Interaction of HLA-DRB1 *03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: A European-wide case study. Ann Rheum Dis. 2012;71:961-965.
5. Compeyrot-Lacassagne S, Feldman BM. Inflammatory myopathies in children. Rheum Dis Clin North Am. 2007;33:525-553, vii.
6. Dugan EM, Huber AM, Miller FW, et al. Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies. Dermatol Online J. 2009;15:2.
7. Dugar M, Cox S, Limaye V, et al. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J. 2011;41:674-679.
8. Espada G, Maldonado Cocco JA, Fertig N, et al. Clinical and serologic characterization of an Argentine pediatric myositis cohort: Identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J Rheumatol. 2009;36:2547-2551.
9. Feldman BM, Reichlin M, Laxer RM, et al. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996;23:1794-1797.
10. Feldman BM, Rider LG, Reed AM, et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371:2201-2212.